Malignant progenitors from patients with CD87+ acute myelogenous leukemia are sensitive to a diphtheria toxin-urokinase fusion protein. [electronic resource]
Producer: 20021212Description: 1316-23 p. digitalISSN:- 0301-472X
- Acute Disease
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- pharmacology
- Cell Division -- drug effects
- Diphtheria Toxin -- genetics
- Drug Delivery Systems
- Drug Screening Assays, Antitumor
- Female
- Humans
- Leukemia, Myeloid -- pathology
- Male
- Middle Aged
- Neoplasm Proteins -- drug effects
- Neoplastic Stem Cells -- drug effects
- Receptors, Cell Surface -- drug effects
- Receptors, Urokinase Plasminogen Activator
- Recombinant Fusion Proteins -- pharmacology
- Tumor Stem Cell Assay
- Urokinase-Type Plasminogen Activator -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.